1. American Cancer Society. Cancer Facts & Figures–2000. Atlanta, GA, American Cancer Society, 2000.
2. The American Cancer Society 1996 Advisory Committee on Diet, Nutrition, and Cancer Prevention. Guidelines on diet, nutrition, and cancer prevention: Reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 1996;46:325-341 (revised 1999).
3. Strecher VJ, DeVellis BM, Becker MH, Rosenstock IM. The role of self-efficacy in achieving behavior change. Health Educ Q 1986;13:73-92.
4. U.S. Dept. of Agriculture. Nutrition and Your Health: Dietary Guidelines for Americans, ed 4, Home & Garden Bulletin No. 232, Washington, DC, U.S. Dept. of Health and Human Services, 1995.
5. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition and the Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Research, 1997.
6. Willett WC. Goals for nutrition for the Year 2000. CA Cancer J Clin 1999;49:331-352.
7. Krauss RM, Deckelbaum RJ, Ernst N, et al. Dietary guidelines for healthy American adults. A statement for health professionals from the Nutrition Committee, American Heart Association. Circulation 1996;94:1795-1800.
8. Shils ME, Olson JA, Shike M, Ross AC. Modern Nutrition in Health and Disease, ed 9. Baltimore, MD, Williams & Wilkins, 1999.
9. Bloch AS. Nutrition Management of the Cancer Patient, Rockville, MA, Aspen Publishers, Inc., 1990.
10. Mahan LK, Escott-Stump S. Krause’s Food, Nutrition & Diet Therapy, ed 9. Philadelphia, PA: W.B.Saunders,1996.
11. Murphy G, Morris L, Lange D. Informed Decisions.. The complete book of cancer diagnosis, treatment, and recovery, New York, Viking, 1997.
12. Monsen ER. Dietary reference intakes for the antioxidant nutrients: Vitamin C, vitamin E, selenium, and carotenoids. J Am Diet Assoc 2000;100:637-640.
13. Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC: National Academy Press, 2000.
14. Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, DC: National Academy Press, 1999.
15. Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, DC: National Academy Press, 2000.
16. National Research Council, Institute of Medicine. Recommended Daily Allowances, ed 10. Washington, DC: National Academy Press, 1989.
17. Kong Q, Lillehei KO. Antioxidant inhibitors for cancer therapy. Med Hypotheses 1998;51:405-409.
18. Labriola D, Livingston R. Possible interactions between dietary antioxidants and chemotherapy. Oncology 1999;13:1003-1008.
19. Lamson DW, Brignall MS. Antioxidants in cancer therapy; their actions and interactions with oncologic therapies. Altern Med Rev 1999;4:304-329.
20. Prasad KN, Kumar A, Kochupillai V, Cole WC. High doses of multiple antioxidant vitamins: Essential ingredients in improving the efficacy of standard cancer therapy. J Am Coll Nutr 1999;18:13-25.
21. Simone CB. Use of therapeutic levels of nutrients to augment oncology care, in Quillin P, Williams RM (eds). Adjuvant Nutrition in Cancer Treatment. Arlington Heights, IL, Cancer Treatment Research Foundation/American College of Nutrition. 1993, pp 99-127, 363-370.
22. Lissoni P, Barni S, Mandala M, et al. Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour in patients with poor clinical status. Eur J Cancer 1999;35:1688-1692.
23. Ghielmini M, Pagani O, de Jong J, et al. Double-blind randomized study on the myeloprotective effect of melatonin in combination with carboplatin and etoposide in advancer lung cancer. Br J Cancer 1999;80:1058-1061.
24. Feuz A, Rapin CH. An observational study of the role of pain control and food adaptation of elderly patients with terminal cancer. J Am Diet Assoc 1994;94:767-770.
25. Herrington A, Herrington JD, Church CA. Pharmacologic options for the treatment of cachexia. Nutr Clin Pract 1997;12:101-113.
26. Tchekmedyian NS. Costs and benefits of nutrition support in cancer. Oncology 1995;9:79-84.
27. Mullen JL. Complications of total parenteral nutrition in the cancer patient. Cancer Treat Rep 1981;65(5):107-113.
28. Wade J, Schimpff S. Epidemiology and prevention of infection in the immunocompromised host, in Rubin R, Young L (eds). Clinical Approach to Infection in the Compromised Host, ed 2. New York, Plenum Press, 1989:5-40.
29. Davidson B, Vander Laan R, Davis A, et al. Ethical reasoning associated with the feeding of terminally ill elderly cancer patients: an international perspective. Cancer Nurs 1990;13:286-292.
30. Ottery FD. Supportive nutrition to prevent cachexia and improve quality of life. Semin Oncol 1995;22(3):98-111.
31. Rivadeneira DE, Evoy D, Fahey TJ, et al. Nutritional support of the cancer patient. CA Cancer J Clin 1998;48:69-80.
32. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report. Obes Res 1998;6(Suppl 2):51S-209S.
33. Shaw J, Humberstone D, Douglas RG, Koea J. Leucine kinetics in patients with disease, non-weight-losing cancer, and cancer cachexia: Studies at the whole-body and tissue level and the response to nutritional support. Surgery 1991;109:37-50.
34. Garlick PJ, McNurlan MA. Protein metabolism in cancer patients. Biochimie 1994;76:713-717.
35. Ottery F. Supportive nutritional management of the patient with pancreatic cancer. Oncology 1996;10(Suppl):26-32.
36. Demark-Wahnefried W, Rimer BK, Winer EP. Weight gain in women diagnosed with breast cancer. J Am Diet Assoc 1997;97:519-526,529.
37. Hunter DJ, Willett WC. Nutrition and breast cancer. Cancer Causes Control 1996;7:56-68.
38. Donegan WL, Hartz AJ, Rimm AA. The association of body weight with recurrent cancer of the breast. Cancer 1978;41(4):1590-1594.
39. Boyd NF, Campbell JE, Germanson T, et al. Body weight and prognosis in breast cancer. J Natl Cancer Inst 1981;67(4):785-789.
40. Jain M, Miller AB. Tumor characteristics and survival of breast cancer patients in relation to premorbid diet and body size. Breast Cancer Res Treat 1997;42(1):43-55.
41. Zhang S, Folsom A, Sellers TA, et al. Better breast cancer survival for postmenopausal women who are less overweight and eat less fat. The Iowa Women’s Health Study. Cancer 1995;76:275-283.
42. Hebert JR, Toporoff E. Dietary exposures and other factors of possible prognostic significance in relation to tumour size and nodal involvement in early-stage breast cancer. Int J Epidemiol 1989;18:518-526.
43. Newman SC, Miller AB, Howe GR. A study of the effect of weight and dietary fat on breast cancer survival time. Am J Epidemiol 1986;123:767-774.
44. Potter JD. Nutrition and colorectal cancer. Cancer Causes Control 1996;7:127-146.
45. Kolonel LN, Nomura AM, Cooney RV. Dietary fat and prostate cancer: Current status. J Natl Cancer Inst 1999;91:414-428.
46. Lees AW, Jenkins HJ, May CL, et al. Risk factors and 10-year breast cancer survival in northern Alberta. Breast Cancer Res Treat 1989;13(2):143-151.
47. Ewertz M, Gillanders S, Meyer L, Zedeler K. Survival of breast cancer patients in relation to factors which affect the risk of developing breast cancer. Int J Cancer 1991;49:526-530.
48. Hebert J, Hurley T, Ma Y. The effect of dietary exposures on recurrence and mortality in early stage breast cancer. Breast Cancer Res Treat 1998;51:17-28.
49. Holm LE, Nordevang E, Hjalmar M, et al. Treatment failure and dietary habits in women with breast cancer. J Natl Cancer Inst 1993;85:32-36
50. Jain M, Miller AB, To T. Premorbid diet and the prognosis of women with breast cancer. J Natl Cancer Inst 1994;86:1390-1397.
51. Saxe GA, Rock CL, Wicha MS, Schottenfeld D. Diet and risk for breast cancer recurrence and survival. Breast Cancer Res Treat 1999;53:241-253.
52. Ingram D. Diet and subsequent survival in women with breast cancer. Br J Cancer 1994;69:592-595.
53. Rohan TE, Hiller JE, McMichael AJ. Dietary factors and survival from breast cancer. Nutr Cancer 1993;20:167-77.
54. Harlan LC, Coates RJ, Block G, et al. Estrogen receptor status and dietary intakes in breast cancer patients. Epidemiology 1993;4:25-31.
55. Holm LE, Callmer E, Hjalmar ML, et al. Dietary habits and prognostic factors in breast cancer. J Natl Cancer Inst 1989;81:1218-1223.
56. Kyogoku S, Hirohata T, Nomura Y, et al. Diet and prognosis of breast cancer. Nutr Cancer 1992;17:271-277.
57. Nomura AM, Marchand LL, Kolonel LN, Hankin JH. The effect of dietary fat on breast cancer survival among Caucasian and Japanese women in Hawaii. Breast Cancer Res Treat 1991;18:S135-141.
58. Gregorio DI, Emrich LJ, Graham S, et al. Dietary fat consumption and survival among women with breast cancer. J Natl Cancer Inst 1985;75:37-41.
59. Rose DP, Connolly JM. Dietary fat and breast cancer metastasis by human tumor xenographs. Breast Cancer Res Treat 1997;46:225-237.
60. Verreault R, Brisson J, Deschenes L, et al. Dietary fat in relation to prognostic indicators in breast cancer. J Natl Cancer Inst 1988;80:819-825.
61. Wu AH, Pike MC, Stram DO. Meta-analysis: dietary fat intake, serum estrogen levels, and the risk of breast cancer. J Natl Cancer Inst 1999;91:529-534.
62. Stoll BA. Essential fatty acids, insulin resistance and breast cancer risk. Nutr Cancer 1998;31:72-77.
63. Byers T, Rock CL, Hamilton KK. Dietary changes after breast cancer: What should we recommend? Cancer Pract 1997;5:317-320.
64. Steinmetz KA, Potter JD. Vegetables, fruit, and cancer prevention: a review. J Am Diet Assoc 1996;96:1027-1039.
65. Zhang S, Hunter DJ, Forman MR, et al. Dietary carotenoids and vitamins A, C, and E and risk of breast cancer. J Natl Cancer Inst 1999;91:547-556.
66. Freudenheim JL, Marshall JR, Vena JE, et al. Premenopausal breast cancer risk and intake of vegetables, fruits, and related nutrients. J Natl Cancer Inst 1996;88:340-348.
67. Rock CL, Saxe GA, Ruffin MT 4th, et al. Carotenoids, vitamin A, and estrogen receptor status in breast cancer. Nutr Cancer 1996;25(3):281-296.
68. Eastwood MA. Interaction of dietary antioxidants in vivo: How fruit and vegetables prevent disease? QJM 1999;92:527-530.
69. Zhang SM, Hunter DJ, Rosner BA, et al. Intakes of fruits, vegetables and related nutrients and the risk of non-Hodgkin’s lymphoma among women. Cancer Epidemiol Biomarkers Prev 2000;9:477-485.
70. Voorrips LE, Goldbohm RA, Brants HA, et al. A prospective cohort study on antioxidant and folate intake and male lung cancer risk. Cancer Epidemiol Biomarkers Prev 2000;9:357-365.
71. The President’s Council on Physical Fitness and Sports. Physical Activity and Health: A Report of the Surgeon General. Atlanta, GA, US Department of Health and Human Services, Centers for Disease Control, National Center for Chronic Disease Prevention and Health Promotion, 1996.
72. Pate RR, Pratt M, Blair SN, et al. Physical activity and public health: A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 1995;273:402-407.
73. Sternfeld B. Cancer and the protective effect of physical activity: The epidemiological evidence. Med Sci Sports Exerc 1992;24:1195-1209.
74. Rohan TE, Fu W, Hiller JE. Physical activity and survival from breast cancer. Eur J Cancer Prev 1995;4:419-424.
75. McTiernan A, Schwartz RS, Potter J, Bowen D. Exercise clinical trials in cancer prevention research. Cancer Epidemiol Biomarkers Prev 1999;8:201-207.
76. McTiernan A, Ulrich C, Kumai C, et al. Anthropometric and hormone effects in an eight-week exercise-diet intervention in breast cancer patients: Results of pilot study. Cancer Epidemiol Biomarkers Prev 1998;7:477-481.
77. Nieman DC, Cook VD,Henson DA, et al. Moderate exercise training and natural killer cell cytotoxic activity in breast cancer patients. Int J Sports Med 1995;16:334-337.
78. Courneya KS, Friedenreich CM. Physical exercise and quality of life following cancer diagnosis: A literature review. Ann Behav Med 1999;21:171-179.
79. Courneya KS, Friedenreich CM. Relationship between exercise pattern across the cancer experience and current quality of life in colorectal cancer survivors. J Altern Complement Med 1997;3:215-226.
80. Dimeo F, Rumberger BG, Keul J. Aerobic exercise as therapy for cancer fatigue. Med Sci Sports Exerc 1998;30:475-478.
81. Nelson JP. Perceived health, self-esteem, health habits and perceived benefits and barriers to exercise in women who have and who have not experienced stage I breast cancer. Oncol Nurs Forum 1991;18:1191-1197.
82. Baldwin,MK, Courneya, KS. Exercise and self-esteem in breast cancer survivors: An application of the exercise and self-esteem model. Journal of Sport and Exercise Psychology 1997;19:347-358.
83. Courneya KS, Friedenreich CM: Relationship between exercise during cancer treatment and current quality of life among survivors of breast cancer. J Psychosoc Oncol 1997;15:35-57.
84. Winningham ML, MacVicar MG, Bondoc M, et al. The effect of aerobic exercise on patient reports of nausea. Oncol Nurs Forum 1989;16:683-689.
85. Dimeo FC, Stieglitz RD, Novelli-Fischer U, et al. Effects of physical activity on the fatigue and psychologic status of cancer patients during chemotherapy. Cancer 1999;85:2273-2277.
86. Mock V, Dow KH, Meares CJ, et al. Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer. Oncol Nurs Forum 1997;24:991-1000.
87. Young-McCaughan S, Sexton DL. A retrospective investigation of the relationship between aerobic exercise and quality of life in women with breast cancer. Oncol Nurs Forum 1991;18:751-757.
88. MacVicar, MG, Winningham, ML. Promoting the functional capacity of cancer patients. Canc Bulletin 1986;38:235-239.
89. MacVicar MG, Winningham ML, Nickel JL. Effects of aerobic interval training on cancer patients’ functional capacity. Nurs Res 1989;38: 348-351
90. Dimeo F, Fetscher S, Lange W, et al. Effects of aerobic exercise on the physical performance and incidence of treatment-related complications after high-dose chemotherapy. Blood 1997;90: 3390-3394.
91. Mock V, Burke MB, Sheehan P, et al. A nursing rehabilitation program for women with breast cancer receiving adjuvant chemotherpy. Oncol Nurs Forum 1994;21:899-907
92. Dimeo F, Bertz H, Finke J, et al. An aerobic exercise program for patients with haematological malignancies after bone marrow transplantation. Bone Marrow Transplant 1996;18:1157-1160.
93. Dimeo FC, Tilmann MH, Bertz H, et al. Aerobic exercise in the rehabilitation of cancer patients after high dose chemotherapy and autologous stem cell transplantation. Cancer 1997; 79:1717-1722.
94. Winningham ML, MacVicar MG, Bondoc M, et al. Effect of aerobic exercise on body weight and composition in patients with breast cancer on adjuvant chemotherapy. Oncol Nurs Forum 1989;16:683-689.
95. Frankel EN, Kanner J, German JB, et al. Inhibition of oxidation of human low density lipoprotein phenolic substances in red wine. Lancet 1993;341:454-457.
96. Hertog MG, Kromhout D, Aravanis C, et al. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med 1995;155:381-386.
97. Stoner GD, Mukhtar H. Polyphenols as cancer chemopreventive agents. J Cell Biochem Suppl 1995;22:169-180.
98. Szarka CE, Grana G, Engstrom PF. Chemoprevention of cancer. Curr Probl Cancer 1994;18:6-79.
99. Kushi M. The Cancer Prevention Diet, New York, St. Martin’s Press, 1983.
100. Cassileth BR. The Alternative Medicine Handbook, New York, WW Norton, 1998.
101. Melina V, Davis B, Harrison V. Becoming Vegetarian. Summertown, TN, Book Publishing Company, 1995.
102. Weitzman S. Alternative nutritional cancer therapies. Int J Cancer Suppl 1998;11:69-72.
103. Roberts S. Alternative nutrition therapies used by oncology patients. Support Line 1998;20:10-17.
104. Lerner M. Choices in Healing, Cambridge, Mass, MIT Press, 1994.
105. Byers T. What can randomized controlled trials tell us about nutrition and cancer prevention? CA Cancer J Clin 1999;49:353-361.
106. The Alpha Tocopherol, Betacarotene Prevention Study Group. The effect of vitamin E and betacarotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-1035.
107. Omenn G, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150-1155.
108. Baltzer L, Berkery R. Oncology: Pocket Guide to Chemotherapy (Revised Edition). St. Louis, Mosby,1995.
109. Facts and Comparisons. St. Louis, Facts and Comparisons, Inc., 2000.
110. Robbers JE, Tyler V. Tyler’s Herbs of Choice: The Therapeutic Use of Phytomedicinals. New York, Haworth Press,1999.
111. Garewal HS, Katz R, Meyskens F, et al. Beta-carotene produces sustained remissions in patients with oral leukoplakia: Results of a multicenter prospective trial. Arch Otolaryngol Head Neck Surg 1999;125:1305-1310.
112. Mackerras D, Irwig L, Simpson JM, et al. Randomized double-blind trial of betacarotene and vitamin C in women with minor cervical abnormalities. Br J Cancer 1999;79:1448-1453.
113. Kaegi E. Unconventional therapies for cancer:5. Vitamins A, C and E. The Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative. CMAJ 1998;158:1483-1488.
114. Bland JS. Phytonutrition, phytotherapy, and phytopharmacology. Altern Ther Health Med 1996;2:73-6.
115. Maxwell SR. Antioxidant vitamin supplements: update of their potential benefits and possible risks. Drug Saf 1999;21:253-266.
116. Sarubin A. The Health Professional’s Guide to Popular Dietary Supplements. Chicago, IL, The American Dietetic Association, 2000.
117. Bloch AS. Alternative nutritional regimens targeted to persons with cancer. Cancer Pract 1999;7:151-153.
118. Block, KI. Dietary impact on quality and quantity of life in cancer patients, in Adjuvant Nutrition in Cancer Treatment. Arlington Heights, IL, Cancer Treatment Research Foundation/American College of Nutrition. 1993, p 99-127.
119. Richardson MA, White JD. Complemen-tary/alternative medicine and cancer research. Cancer Pract 2000;8:45-48.
120. Kim JH, Brown S, Walker E. The use of high dose vitamins as an adjunct to conventional cancer treatment, in Prasad KN, Cole WC (eds). Cancer and Nutrition. Washington, DC, IOS Press, 1998, pp 205-212.
121. Cassileth BR, Chapman CC. Alternative medicine: A ten year update. Cancer Invest 1996;14:396-404.
122. Cassileth BR, Chapman CC. Alternative and complementary cancer therapies. Cancer 1996;77:1026-1034.
123. Eisenberg DM. Advising patients who seek alternative medical therapies. Ann Intern Med 1997; 127: 61-69.
124. Eisenberg DM, Kessler RC, Foster C, et al. Unconventional medicine in the United States: prevalence, costs and pattern of use. NEJM 1993;328:246-252.
125. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997, results of a follow-up national survey. JAMA 1998; 280:1569-1575.
126. Ernst E, Resch KL, White AR. Complementary medicine, what physicians think of it: A meta analysis. Arch Intern Med 1995;155:2405-2408.
127. Gray RE, Greenberg M, Fitch M, et al. Perspectives of cancer survivors interested in unconventional therapies. J Psychsoc Oncol 1997;15:149-171.
128. Montbriand MJ. Decision tree model describing alternate health care choices made by oncology patients. Cancer Nurs 1995;18(2):104-117.
129. Montbriand MJ. Alternative therapies as control behaviours used by cancer patients. J Adv Nurs 1995;22:646-654.
130. Paramore LC. Use of alternative therapies: estimates from the 1994 Robert Wood Johnson Foundation national access to care survey. J Pain Symptom Manage 1997;13:83-89.
131. Roberts S. Alternative nutrition therapies used by oncology patients. Support Line 1998;20:10-17.
132. Burstein HJ, Gelber S, Guadagnoli E, Weeks JC. Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 1999;340:1733-1739.
133. Bass FB, Cox RH. The need for dietary counseling of cancer patients as indicated by nutrient and supplement intake. J Am Diet Assoc 1995;95:1319-1321.
134. PDR for herbal medicines. Montvale, NJ, Medical Economics Company, 1999.
135. Boik J. Cancer & Natural Medicine: A Textbook Of Basic Science And Clinical Research. Princeton, MN, Oregon Medical Press, 1995.
136. Miller LG. Herbal medicinals, selected clinical considerations focusing on known or potential drug herb interactions. Arch Intern Dis 1998:158:2200-2211.
137. German Federal Institute for Drugs and Medical Devices. The Complete German Commission E Monographs. Austin, TX, American Botanical Council, 1998.
138. Tyler VE. The Honest Herbal. Binghamton, NY, Pharmaceutical Products Press, 1993.
139. Simonsen N, van’t Veer P, Strain JJ, et al. Adipose tissue omega-3 and omega-6 fatty acid content and breast cancer in the EURAMIC study. European Community Multicenter Study on Antioxidants, Myocardial Infarction, and Breast Cancer. Am J Epidem 1998;147:342-352.
140. Cave WT Jr. Omega-3 polyunsaturated fatty acids in rodent models of breast cancer. Breast Cancer Res Treat 1997;46:239-246.
141. Griffini P, Fehres O, Klieverik L, et al. Dietary omega-3 polyunsaturated fatty acids promote colon carcinoma metastasis in rat liver. Cancer Res 1998;58:3312-3319.
142. Phillips S, Ruggier R, Hutchinson SE. Zingiber officinale (ginger) – an antiemetic for day case surgery. Anaethesia 1993;48:715-717.
143. Aikins MP. Alternative therapies for nausea and vomiting of pregnancy. Obstet Gynecol 1998;91:149-155.
144. Blasinsky J, Milan S. Implementing antiemetic guidelines for the oncology patient: an interdisciplinary quality improvement project. ON-LINE 1998;6:4-6.
145. Lieberman B. The Soy Story. Nutrition Action Newletter 1998; 2:1-7.
146. Yan L, Yee JA, McGuire MH, Graef GL. Effect of dietary supplementation of soybeans on experimental metastasis of melanoma cells in mice. Nutr Cancer 1997;29:1-6.
147. Messina M. Soy and breast cancer risk. The Soy Connection 1999;7:1-5.
148. Petrakis NL, Barnes S, King EB, et al. Stimulatory influence of soy protein isolates on breast secretion in pre- and postmenopausal women. Cancer Epidemiol Biomarkers Prev 1996;5(10)785-794
149. McMichael-Phillips DF, Harding C, Morton M, et al. Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast. Am J Clin Nutr 1998;68:1431S-1435S.
150. Hsieh CY, Santell RC, Haslam SZ, Helferich WG. Estrogenic effects of genistein on the growth of estrogen receptor positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res 1998; 58:3833-3838
151. Kyle E, Neckers L, Takimoto C, et al. Genistein-induced apoptosis of prostate cancer cells is preceded by a specific decrease in focal adhesion kinase activity. Mol Pharmacol 1997;51:193-200.
152. Moyad MA. Soy, disease prevention and prostate cancer. Semin Urol Oncol 1999; 17:97-102
153. Lieberman, R. Chemoprevention Trials of Soy Isoflavones and Other Promising Dietary Nutrients: Overview of NCI Phase II/III Cancer Prevention Trials. Third International Symposium on the Role of Soy in Preventing and Treating Chronic Disease, Washington, D.C., October 31 - November 3, 1999.
154. Peterson G, Barnes S. Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells. Cell Growth Differ 1996;7:1345-1351.
155. Lu L, Cree M, Josyula S, et al. Increased urinary excretion of 2-hydroxyestrone but not 16(-hydroxyestrone in premenopausal women during soya diet containing isoflavones. Cancer Res 2000;60:1299-1305.
156. Malkowicz SB, Broderick GA, Zoltick B, et al. Phase I study of oral Bowman-Birk Inhibitor Concentrate (BBIC), a soy protein in patient with lower urinary tract symptoms. J Urol 1999;161:128.
157. Braekman J et al. Efficacy and safety of the extract of serenoa repens in the treatment of benign prostatic hyperplasia: Therapeutic equivalence between twice and once daily dosage forms. Phytother Res 1997; 11: 558.
158. Weisburger JH. Tea and health: The underlying mechanisms. Proc Soc Biol Med 1999;220:271-275.
159. Bushman J. Green tea and cancer in humans: A review of the literature. Nutr Cancer 1998;31:151-159.
160. Nakachi K, Suemasu K, Suga K, et al. Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn J Cancer Res 1998;89:254-261.
161. Gupta S, Ahmad N, Mukhtar H. Prostate cancer chemoprevention by green tea. Semin Urol Oncol 1999;17:70-76.
162. Gupta S, Ahmad N, Mohan RR, et al. Prostate cancer chemoprevention by green tea: In vitro and in vivo inhibition of testosterone-mediated induction of ornithine decarboxylase. Cancer Res 1999;59:2115-2120.
163. Bianchi GD, Cerhan JR, Parker AS, et al. Tea consumption and risk of bladder and kidney cancers in a population-based case-control study. Am J Epidemiol 2000;151:377-383.
164. Brown MD. Green tea (Camellia sinensis) extract and its possible role in the prevention of cancer. Altern Med Rev 1999;4:360-370.
165. Mukhtar H, Ahmad N. Green tea in chemoprevention of cancer. Toxicol Sci 1999;52: 111-117.
166. Hayes RB, Ziegler RG, Gridley G, et al. Dietary factors and risks for prostate cancer among Blacks and Whites in the United States. Cancer Epidemiol Biomarkers Prev 1999;8: 25-34.
167. Fair WR, Fleshner NE, Heston W. Cancer of the prostate: A nutritional disease? Urology 1997;50:840-848.
168. Giovannucci E. Tomatoes, tomato-based products, lycopene, and cancer: Review of the epidemiologic literature. J Natl Cancer Inst 1999;91:317-331.
169. Gann PH, Ma J, Giovannucci E, et al. Lower prostate cancer risk in men with elevated plasma lycopene levels: Results of a prospective analysis. Cancer Res 1999;59;1225-1230.
170. Clinton SK, Emenhiser C, Schwartz SJ, et al. cis-trans Lycopene isomers, carotenoids, and retinol in the human prostate. Cancer Epidemiol Biomarkers Prev 1996;5:823-833.
171. Clark LC, Combs GF Jr, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. JAMA 1996;276:1957-1963.
172. Yoshizawa K, Willet WC, Morris SJ, et al. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst 1998;90:1219-1224.
173. Heinonen OP, Albanes D, Virtamo J, et al. Prostate cancer and supplementation with alpha-tocoperol and Betacarotene: Incidence and mortality in a controlled trial. J Natl Cancer Inst 1998;90:440-446.
174. Yusuf S, Dagenais G, Pogue J, et al. The Heart Outcomes Prevention Evaluation Study Investigators. Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med 2000;342:154-160.
176. Giovannucci E, Rimm E, Wolk A, et al. Calcium and fructose intake in relation to risk of prostate cancer. Cancer Res 1998;58:442-447.
177. Ziegler RG, Mayne ST, Swanson CA. Nutrition and lung cancer. Cancer Causes Control 1996;7:157-177.
178. Pastorino U, Infante M, Maioli M, et al. Adjuvant treatment of early stage lung cancer with high-dose vitamins. J Clin Oncol 1993;11:1216-1222.
179. McMahon K, Decker G, Ottery FD. Integrating proactive nutritional assessment in clinical practices to prevent complications and cost. Semin Oncol 1998;25:20-27.
180. Bielder, LM, Smith JC. Effects of radiation therapy and drugs on cell turnover and taste, in Getchell T, Barotoshuk L, Doty R, Snow J (eds). Smell and taste in health and disease. New York, Raven Press, 1991, p 753.
181. Engelking C, Wickham R, Iwamoto, R. Cancer-related gastrointestinal symptoms: dilemmas in assessment and management. Oncologist 1996; 1:1-31.
182. Goodwin WJ Jr, Byers PM. Nutritional management of the head and neck cancer patient. Med Clin North Am 1993;77:597-610.
183. Stricklin LA. Nutritional aspects of supportive care: An interview with Faith Ottery MD, PhD. Supportive Care. 1996; 1: 1-31.
184. Donaldson SS, Lenon RA. Alterations of nutritional status: Impact of chemotherapy and radiation therapy. Cancer 1979; 43:2036-2052.
185. Moghissi K, Teasdale P, Dench M. Comparison between preoperative enteral (nasogastric tube) and parenteral feeding in patients with cancer of the esophagus undergoing surgery (Abstract) JPEN. 1982;6:355.
186. Murphy DW, Castell DO. Nutrition and gastrointestinal disease, in Jeejeebhoy KN (ed), Current Therapy in Nutrition. Philadelphia: B.C. Decker, 1988.
187. Lanza E, Schatzkin A, Ballard-Barbash R, et al. The polyp prevention trial II: Dietary intervention program and participant baseline dietary characteristics. Cancer Epidemiol Biomarkers Prev 1996;5(5):385-392.
188. Schatzkin A, Lanza E, Corle D, et al. The Polyp Prevention Trial Study Group. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. N Engl J Med 2000;342:1149-1155.
189. Alberts DS, Martinez ME, Roe DJ, et al. The Phoenix Colon Cancer Prevention Physician’s Network. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. N Engl J Med 2000;342:1156-1162.
190. Kim YI. Folate and cancer prevention: A new medical application of folate beyond hyperhomocysteinemia and neural tube defects. Nutr Rev 1999;57:314-321.
|Remember we are NOT Doctors and have NO medical training.|
This site is like an Encyclopedia - there are many pages, many links on many topics.
Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.